Choice of high-deductible health plans among enrollees with a substance use disorder.


Journal

Journal of substance use and addiction treatment
ISSN: 2949-8759
Titre abrégé: J Subst Use Addict Treat
Pays: United States
ID NLM: 9918541186406676

Informations de publication

Date de publication:
11 2023
Historique:
received: 30 11 2022
revised: 20 04 2023
accepted: 28 08 2023
pmc-release: 01 11 2024
medline: 2 10 2023
pubmed: 3 9 2023
entrez: 2 9 2023
Statut: ppublish

Résumé

High-deductible health plans (HDHPs) expose enrollees to increased out-of-pocket costs for their medical care, which can exacerbate the undertreatment of substance use disorders (SUDs). However, the factors that influence whether an enrollee with SUD chooses an HDHP are not well understood. In this study, we examine the factors associated with an individual with an SUD's decision to enroll in an HDHP. Using de-identified administrative commercial claims and enrollment data from OptumLabs (2007-2017), we identified individuals at employers offering at least one HDHP and one non-HDHP plan. We modeled whether an enrollee chose an HDHP using linear regression on plan and enrollee demographic characteristics. Key plan characteristics included whether a plan had a health savings account (HSA) or a health reimbursement arrangement (HRA). Key demographic variables included age, race/ethnicity, census block income range, census block highest educational attainment, and sex. We separately investigate new enrollment decisions (i.e., not previously enrolled in an HDHP) and re-enrollment decisions, as well as decisions among single enrollees and families of differing sizes. The study also adjusted models for additional plan characteristics, employer and year fixed effects, and census division. Robust standard errors were clustered at the employer level. The sample comprised 30,832 plans and 318,334 enrollees. Among enrollees with new enrollment decisions, 24.6 % chose an HDHP; 93.8 % of HDHP enrollees chose to re-enroll in an HDHP. The study found the presence of a plan HRA to be associated with a higher probability of new and re-enrollment in an HDHP. We found that older enrollees with SUD were less likely to newly enroll in an HDHP, while enrollees who were non-White, living in lower-income census blocks, and living in lower educational attainment census blocks were more likely to newly enroll in an HDHP. Higher levels of health care utilization in the prior year were associated with a lower probability of newly enrolling in an HDHP but associated with a higher probability of re-enrolling. Given the emerging evidence that HDHPs may discourage SUD treatment, greater HDHP enrollment could exacerbate health disparities.

Identifiants

pubmed: 37659697
pii: S2949-8759(23)00203-5
doi: 10.1016/j.josat.2023.209152
pmc: PMC10565842
mid: NIHMS1929384
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

209152

Subventions

Organisme : NIDA NIH HHS
ID : P30 DA035772
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA044201
Pays : United States
Organisme : AHRQ HHS
ID : T32 HS000029
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH109436
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Psychiatr Serv. 2011 Nov;62(11):1273-81
pubmed: 22211205
PLoS One. 2013;8(2):e56154
pubmed: 23418528
Health Aff (Millwood). 2006 Jul-Aug;25(4):1070-8
pubmed: 16835188
Health Serv Res. 2011 Feb;46(1 Pt 1):138-54
pubmed: 20849558
Health Serv Res. 2016 Oct;51(5):1939-59
pubmed: 26840191
N Engl J Med. 2016 Jul 28;375(4):357-68
pubmed: 27464203
Adm Policy Ment Health. 2006 May;33(3):388-97
pubmed: 16755397
JAMA. 2000 Oct 4;284(13):1689-95
pubmed: 11015800
Psychiatr Serv. 2020 Sep 1;71(9):920-927
pubmed: 32438887
Am J Manag Care. 2022 Oct;28(10):530-536
pubmed: 36252172
Psychiatr Serv. 2022 May;73(5):518-525
pubmed: 34587784
J Health Econ. 2016 Mar;46:33-51
pubmed: 26851386
Health Serv Res. 2018 Aug;53 Suppl 1:2718-2734
pubmed: 29058316
J Health Econ. 2017 Sep;55:61-75
pubmed: 28712437
Drug Alcohol Depend. 2022 Dec 1;241:109681
pubmed: 36370532
Health Serv Res. 2004 Aug;39(4 Pt 2):1167-88
pubmed: 15230919
Addiction. 2016 Aug;111(8):1376-84
pubmed: 26899802
NCHS Data Brief. 2018 Aug;(317):1-8
pubmed: 30156534
Health Serv Res. 2014 Apr;49(2):609-27
pubmed: 24800305
Health Aff (Millwood). 2015 Dec;34(12):2077-85
pubmed: 26643628
Health Aff (Millwood). 2017 Oct 1;36(10):1762-1768
pubmed: 28971921
J Gen Intern Med. 2012 Sep;27(9):1105-11
pubmed: 22249829
Med Care. 2022 Mar 1;60(3):256-263
pubmed: 35026792
Health Aff (Millwood). 2008 Nov-Dec;27(6):1671-9
pubmed: 18997225
Health Serv Res. 2004 Aug;39(4 Pt 2):1091-112
pubmed: 15230913
J Gen Intern Med. 2022 Mar;37(4):769-776
pubmed: 34405345
Health Serv Res. 2020 Feb;55(1):119-127
pubmed: 31657012

Auteurs

Mark K Meiselbach (MK)

Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America. Electronic address: mark.meiselbach@jhu.edu.

Haiden A Huskamp (HA)

Department of Health Care Policy, Harvard Medical School, Boston, MA, United States of America.

Julia C P Eddelbuettel (JCP)

Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America; PhD Program in Health Policy, Harvard University, Cambridge, MA, United States of America.

Alene Kennedy-Hendricks (A)

Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.

Mara A G Hollander (MAG)

Department of Public Health Sciences, University of North Carolina - Charlotte, Charlotte, NC, United States of America.

Cameron Schilling (C)

Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.

Alisa B Busch (AB)

Department of Health Care Policy, Harvard Medical School, Boston, MA, United States of America; McLean Hospital, Boston, MA, United States of America; Department of Psychiatry, Harvard Medical School, Boston, MA, United States of America.

Elizabeth A Stuart (EA)

Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.

Colleen L Barry (CL)

Cornell Jeb E. Brooks School of Public Policy, Ithaca, NY, United States of America.

Matthew D Eisenberg (MD)

Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America; Johns Hopkins Carey Business School, Baltimore, MD, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH